Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Berglund

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Vaccine|February 24, 2020
Therapeutic efficacy of PD1/PDL1 blockade in B16 melanoma is greatly enhanced by immunization with dendritic cell-targeting lentiviral vector and protein vaccineTina Chang Albershardt, Andrea Jean Parsons, Rebecca Susan Reeves, et al.
Plos One|December 2, 2021
Intratumoral expression of IL-12 from lentiviral or RNA vectors acts synergistically with TLR4 agonist (GLA) to generate anti-tumor immunological memoryJardin A Leleux, Tina C Albershardt, Rebecca Reeves, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2017
HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T CellsEdmund G Wee, Beatrice Ondondo, Peter Berglund, et al.
Cancer Gene Therapy|February 10, 2023
Clinical trials of self-replicating RNA-based cancer vaccinesMichael A Morse, Erika J Crosby, Jeremy Force, et al.
Science (New York, N.Y.)|May 29, 2004
CD8+ T cell cross-priming via transfer of proteasome substratesChristopher C Norbury, Sameh Basta, Keri B Donohue, et al.
BMJ Open|November 6, 2019
Structural brain changes in hyperthyroid Graves' disease: protocol for an ongoing longitudinal, case-controlled study in Göteborg, Sweden-the CogThy projectMats Olof Holmberg, Helge Malmgren, Peter Berglund, et al.
Molecular Pharmaceutics|August 9, 2013
RNA replicon delivery via lipid-complexed PRINT protein particlesJing Xu, J Christopher Luft, Xianwen Yi, et al.
Plos Currents|December 24, 2009
Rapid development of an efficacious swine vaccine for novel H1N1Ryan Vander Veen, Kurt Kamrud, Mark Mogler, et al.
Journal of Virology|May 28, 2010
In vitro and in vivo characterization of microRNA-targeted alphavirus replicon and helper RNAsKurt I Kamrud, V McNeil Coffield, Gary Owens, et al.
The Journal of Clinical Investigation|August 4, 2010
An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancerMichael A Morse, Amy C Hobeika, Takuya Osada, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Vaccine|February 24, 2020
Therapeutic efficacy of PD1/PDL1 blockade in B16 melanoma is greatly enhanced by immunization with dendritic cell-targeting lentiviral vector and protein vaccineTina Chang Albershardt, Andrea Jean Parsons, Rebecca Susan Reeves, et al.
Plos One|December 2, 2021
Intratumoral expression of IL-12 from lentiviral or RNA vectors acts synergistically with TLR4 agonist (GLA) to generate anti-tumor immunological memoryJardin A Leleux, Tina C Albershardt, Rebecca Reeves, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2017
HIV-1 Conserved Mosaics Delivered by Regimens with Integration-Deficient DC-Targeting Lentiviral Vector Induce Robust T CellsEdmund G Wee, Beatrice Ondondo, Peter Berglund, et al.
Cancer Gene Therapy|February 10, 2023
Clinical trials of self-replicating RNA-based cancer vaccinesMichael A Morse, Erika J Crosby, Jeremy Force, et al.
Science (New York, N.Y.)|May 29, 2004
CD8+ T cell cross-priming via transfer of proteasome substratesChristopher C Norbury, Sameh Basta, Keri B Donohue, et al.
BMJ Open|November 6, 2019
Structural brain changes in hyperthyroid Graves' disease: protocol for an ongoing longitudinal, case-controlled study in Göteborg, Sweden-the CogThy projectMats Olof Holmberg, Helge Malmgren, Peter Berglund, et al.
Molecular Pharmaceutics|August 9, 2013
RNA replicon delivery via lipid-complexed PRINT protein particlesJing Xu, J Christopher Luft, Xianwen Yi, et al.
Plos Currents|December 24, 2009
Rapid development of an efficacious swine vaccine for novel H1N1Ryan Vander Veen, Kurt Kamrud, Mark Mogler, et al.
Journal of Virology|May 28, 2010
In vitro and in vivo characterization of microRNA-targeted alphavirus replicon and helper RNAsKurt I Kamrud, V McNeil Coffield, Gary Owens, et al.
The Journal of Clinical Investigation|August 4, 2010
An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancerMichael A Morse, Amy C Hobeika, Takuya Osada, et al.
Pageof 5